title: Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves.
abstract: Treatments with two-small molecule tropomyosin receptor kinase B (trkB) ligands, 7,8 dihydroxyflavone (7,8 DHF) and deoxygedunin, were evaluated for their ability to promote the regeneration of cut axons in injured peripheral nerves in mice in which sensory and motor axons are marked by YFP. Peripheral nerves were cut and repaired with grafts from strain-matched, nonfluorescent donors and secured in place with fibrin glue. Lengths of profiles of regenerating YFP(+) axons were measured 2 wk later from confocal images. Axon regeneration was enhanced when the fibrin glue contained dilutions of 500-nM solution of either small-molecule trkB agonist. In mice in which the neurotrophin receptor trkB is knocked out selectively in neurons, axon regeneration is very weak, and topical treatment with 7,8 DHF had no effect on axon regeneration. Similar treatments with deoxygedunin had only a modest effect. In conditional BDNF knockout mice, topical treatments with either 7,8 DHF or deoxygedunin resulted in a reversal of the poor regeneration found in controls and produced significant enhancement of regeneration. In WT mice treated with 2 wk of daily i.p. injections of either 7,8 DHF or deoxygedunin (5 mg/kg), regenerating axon profiles were nearly twice as long as in controls. Restoration of direct muscle responses evoked by sciatic nerve stimulation to pretransection levels over an 8-wk survival period was found only in the treated mice. Treatments with either small-molecule trkB agonist enhanced axon regeneration and muscle reinnervation after peripheral nerve injuries.
authors.affiliation: Departments of Cell Biology and Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322.
authors.forename: Arthur W
authors.initials: AW
authors.lastname: English
authors.forename: Kevin
authors.initials: K
authors.lastname: Liu
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Nicolini
authors.forename: Amanda M
authors.initials: AM
authors.lastname: Mulligan
authors.forename: Keqiang
authors.initials: K
authors.lastname: Ye
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D001426:Bacterial Proteins; D005071:Evoked Potentials / Q000502:physiology; D015718:Fibrin Tissue Adhesive / Q000494:pharmacology*; D044950:Flavanones / Q000494:pharmacology*; D036701:Limonins / Q000494:pharmacology*; D016014:Linear Models; D008164:Luminescent Proteins; D051379:Mice; D009416:Nerve Regeneration / Q000187:drug effects / Q000502:physiology*; D020813:Receptor, trkB / Q000819:agonists*
chemical_list: C478869:7,8-dihydroxyflavanone; D001426:Bacterial Proteins; D015718:Fibrin Tissue Adhesive; D044950:Flavanones; D036701:Limonins; D008164:Luminescent Proteins; C054562:yellow fluorescent protein, Bacteria; C106014:gedunin; D020813:Receptor, trkB
references.citation: J Neurosci. 2011 Sep 7;31(36):12889-99
references.pmid: 21900567
references.citation: Neurosurg Focus. 2009 Feb;26(2):E3
references.pmid: 19228105
references.citation: Neuropsychopharmacology. 2012 Jan;37(2):434-44
references.pmid: 21900882
references.citation: PLoS One. 2010 Jul 13;5(7):e11528
references.pmid: 20644624
references.citation: Eur J Neurosci. 2000 Dec;12(12):4381-90
references.pmid: 11122348
references.citation: J Mol Neurosci. 2013 Jan;49(1):96-104
references.pmid: 23054592
references.citation: Muscle Nerve. 2012 Feb;45(2):274-6
references.pmid: 22246885
references.citation: Eur J Neurosci. 2000 Dec;12(12):4171-80
references.pmid: 11122329
references.citation: J Neurosci. 2012 Apr 4;32(14):5002-9
references.pmid: 22492055
references.citation: Eur J Neurosci. 2005 May;21(10):2624-34
references.pmid: 15926911
references.citation: J Reconstr Microsurg. 2009 Jul;25(6):339-44
references.pmid: 19301234
references.citation: Genes Brain Behav. 2012 Jul;11(5):503-12
references.pmid: 22530815
references.citation: Dev Neurobiol. 2007 Feb 1;67(2):158-72
references.pmid: 17443780
references.citation: Nat Neurosci. 2002 Nov;5 Suppl:1046-50
references.pmid: 12403983
references.citation: J Med Chem. 2010 Dec 9;53(23):8274-86
references.pmid: 21073191
references.citation: Exp Neurol. 2008 Jun;211(2):489-93
references.pmid: 18420199
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2687-92
references.pmid: 20133810
references.citation: J Med Chem. 2012 Oct 11;55(19):8524-37
references.pmid: 22984948
references.citation: J Neurosci. 1997 Jan 1;17(1):470-6
references.pmid: 8987771
references.citation: J Card Surg. 2003 Nov-Dec;18(6):480-5
references.pmid: 14992096
references.citation: Neuroreport. 2001 Apr 17;12(5):1067-72
references.pmid: 11303747
references.citation: Mol Neurobiol. 1997 Feb-Apr;14(1-2):67-116
references.pmid: 9170101
references.citation: J Neurosci. 2000 Apr 1;20(7):2602-8
references.pmid: 10729340
references.citation: Microsurgery. 1998;18(7):397-405
references.pmid: 9880154
references.citation: J Biomed Mater Res A. 2009 Dec;91(3):719-29
references.pmid: 19048635
references.citation: J Cell Biol. 1993 Oct;123(2):455-65
references.pmid: 8408225
references.citation: Brain Res Mol Brain Res. 1996 Mar;36(2):280-6
references.pmid: 8965648
references.citation: Exp Neurol. 2005 Oct;195(2):278-92
references.pmid: 15950970
references.citation: Exp Neurol. 2002 Jan;173(1):77-85
references.pmid: 11771940
references.citation: Neuron. 2000 Oct;28(1):41-51
references.pmid: 11086982
references.citation: J Neurosci. 2011 Dec 7;31(49):17800-10
references.pmid: 22159096
references.citation: Transl Psychiatry. 2012 Dec 18;2:e205
references.pmid: 23250006